Literature DB >> 23709688

Decreased frequency of CD73+CD8+ T cells of HIV-infected patients correlates with immune activation and T cell exhaustion.

Ilona Tóth1, Anh Q Le, Philip Hartjen, Adriana Thomssen, Verena Matzat, Clara Lehmann, Christoph Scheurich, Claudia Beisel, Philipp Busch, Olaf Degen, Ansgar W Lohse, Thomas Eiermann, Gerd Fätkenheuer, Dirk Meyer-Olson, Maximilian Bockhorn, Joachim Hauber, Jan van Lunzen, Julian Schulze Zur Wiesch.   

Abstract

Recent studies indicate that murine Tregs highly express the ENTDP1, as well as the 5'-NT and thereby, suppress Teff function by extracellular adenosine production. Furthermore, CD73 seems to play a role as costimulatory molecule for T cell differentiation. In this study, we analyzed the expression of CD73 on peripheral and lymph nodal Teffs and Tregs in a cohort of 95 HIV patients at different stages of disease, including LTNP and ECs. In contrast to murine Tregs, CD73 was only expressed on a small minority (∼10%) of peripheral Tregs. In contrast, we see high expression of CD73 on peripheral CD8(+) T cells. In HIV infection, CD73 is markedly reduced on all Teffs and Tregs, regardless of the memory subtype. On CD8(+) T cells, a positive correlation between CD73 expression and CD4 counts (P=0.0003) was detected. CD73 expression on CD8(+) T cells negatively correlated with HLA-DR (<0.0001) and PD1 (P=0.0457) expression. The lower CD73 expression on CD8(+) T cells was partially reversible after initiation of ART (P=0.0016). Functionally, we observed that CD8(+)CD73(+) T cells produce more IL-2 upon HIV-specific and unspecific stimulation than their CD73(-) counterparts and show a higher proliferative capacity. These data indicate that down-regulation of CD73 on CD8(+) T cells correlates with immune activation and leads to functional deficits in HIV infection.

Entities:  

Keywords:  5′-ectonucleotidase; CD39; adenosine; elite controller; regulatory T cell

Mesh:

Substances:

Year:  2013        PMID: 23709688     DOI: 10.1189/jlb.0113018

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  34 in total

1.  Characteristics of splenic CD8+ T cell exhaustion in patients with hepatitis C.

Authors:  K Sumida; S Shimoda; S Iwasaka; S Hisamoto; H Kawanaka; T Akahoshi; T Ikegami; K Shirabe; N Shimono; Y Maehara; C Selmi; M E Gershwin; K Akashi
Journal:  Clin Exp Immunol       Date:  2013-10       Impact factor: 4.330

2.  Editorial: CD73 deficiency and immune dysregulation in HIV infection: cause or effect?

Authors:  Linda F Thompson
Journal:  J Leukoc Biol       Date:  2013-10       Impact factor: 4.962

3.  Critical Role for the Adenosine Pathway in Controlling Simian Immunodeficiency Virus-Related Immune Activation and Inflammation in Gut Mucosal Tissues.

Authors:  Tianyu He; Egidio Brocca-Cofano; Delbert G Gillespie; Cuiling Xu; Jennifer L Stock; Dongzhu Ma; Benjamin B Policicchio; Kevin D Raehtz; Charles R Rinaldo; Cristian Apetrei; Edwin K Jackson; Bernard J C Macatangay; Ivona Pandrea
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

4.  Immune Activation and Inflammation in People With Human Immunodeficiency Virus: Challenging Targets.

Authors:  Netanya S Utay; Edgar T Overton
Journal:  J Infect Dis       Date:  2020-04-27       Impact factor: 5.226

Review 5.  Adenosine signaling and adenosine deaminase regulation of immune responses: impact on the immunopathogenesis of HIV infection.

Authors:  Daniela F Passos; Viviane M Bernardes; Jean L G da Silva; Maria R C Schetinger; Daniela Bitencourt Rosa Leal
Journal:  Purinergic Signal       Date:  2018-08-10       Impact factor: 3.765

6.  A Randomized, Placebo-Controlled, Pilot Clinical Trial of Dipyridamole to Decrease Human Immunodeficiency Virus-Associated Chronic Inflammation.

Authors:  Bernard J C Macatangay; Edwin K Jackson; Kaleab Z Abebe; Diane Comer; Joshua Cyktor; Cynthia Klamar-Blain; Luann Borowski; Delbert G Gillespie; John W Mellors; Charles R Rinaldo; Sharon A Riddler
Journal:  J Infect Dis       Date:  2020-04-27       Impact factor: 5.226

Review 7.  The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets.

Authors:  Bertrand Allard; Maria Serena Longhi; Simon C Robson; John Stagg
Journal:  Immunol Rev       Date:  2017-03       Impact factor: 12.988

Review 8.  Connection between γδ T-cell- and Adenosine- Mediated Immune Regulation in the Pathogenesis of Experimental Autoimmune Uveitis.

Authors:  Dongchun Liang; Hui Shao; Willi K Born; Rebecca L O'Brien; Henry J Kaplan; Deming Sun
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

9.  CD73: an emerging checkpoint for cancer immunotherapy.

Authors:  Siqi Chen; Derek A Wainwright; Jennifer D Wu; Yong Wan; Daniela E Matei; Yi Zhang; Bin Zhang
Journal:  Immunotherapy       Date:  2019-06-21       Impact factor: 4.196

10.  Differential transcriptional and functional properties of regulatory T cells in HIV-infected individuals on antiretroviral therapy and long-term non-progressors.

Authors:  Shima Shahbaz; Juan Jovel; Shokrollah Elahi
Journal:  Clin Transl Immunology       Date:  2021-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.